30.05.2014 - We recommend opening short positions on Abbvie

The price of pharmaceutical company Abbvie has once again reached the strong level of 54.25 and now is consolidating near it. Furthermore, at the moment the company quotes reached the inclined resistance line and in case of breaking through it, we recommend to open short positions with a stop above 54.50 and objectives at 51.00, 49.00 and 48.00. Confirmation of the signal to sell the will be fixing price below 53.00. We expect a price decline in the medium term.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.